News Search Results
Sep 09, 2025, 20:43 ET Seegene e Springer Nature aprono le candidature per i Nature Awards MDx Impact Grants 2025-2026
sviluppo, produzione e commercializzazione di tecnologie sindromiche basate sulla real-time PCR. Durante la pandemia di COVID-19, Seegene ha fornito più di 340 milioni di test in oltre 100 paesi, confermando il proprio impatto a livello internazionale. La tecnologia di
More news about: Seegene Inc.
Sep 09, 2025, 16:00 ET NaaS Technology Inc. to Hold Annual General Meeting on October 10, 2025
NaaS' ability to protect and enforce its intellectual property rights; NaaS' ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China
More news about: NaaS Technology Inc.
Sep 09, 2025, 10:52 ET STAT Marks 10 Years of Reporting from the Frontiers of Health and Medicine
organization to seize on the novel coronavirus as a potentially catastrophic global health threat, and consistently produced vital, prescient coverage of the Covid-19 pandemic. In March 2020, the New York Times described STAT as "the medical news site that
More news about: STAT
Sep 09, 2025, 10:30 ET Lateral Flow Assays Market Size will Hit US$ 15.68 Billion by 2033, Driven by Infectious Disease Testing and AI-Powered Diagnostics | DataM Intelligence
Lateral flow assays (LFAs) have become indispensable tools for rapid and cost-effective testing. Their adoption surged globally during the COVID-19 pandemic, and the momentum has continued with innovations in sandwich assays, multiplex detection formats, and portable lateral flow readers. The
More news about: DataM Intelligence 4 Market Research LLP
Sep 09, 2025, 10:01 ET Next Generation Antibody Therapeutics Market Size will Hit $22.88 Billion by 2033, Fueled by Breakthroughs in Oncology and AI-Driven Drug Design | DataM Intelligence
segment, valued at nearly US$ 0.8 billion, with companies developing next-gen antibodies for viral threats including COVID-19 and HIV. Ophthalmology and rare diseases each contributed smaller but rapidly growing market shares, highlighting the diversification of antibody
More news about: DataM Intelligence 4 Market Research LLP
Sep 09, 2025, 09:19 ET Educator Positivity Rebounds, AI Use in Classrooms Continues to Surge
Sept. 9, 2025 /PRNewswire/ -- Educators are more optimistic about their profession than they have been since before the COVID-19 pandemic began. Still, less than half report overall positive feelings, with decreasing funding and support for education topping the list of concerns,
More news about: HMH Education Company
Sep 09, 2025, 09:00 ET LINE LAWSUIT ALERT: Levi & Korsinsky Notifies Lineage, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer
More news about: Levi & Korsinsky, LLP
Sep 09, 2025, 08:05 ET Altesa BioSciences and bioMérieux Announce Collaboration for Altesa's Upcoming Phase 2B COPD Clinical Trial
single patient sample, the panel will indicate whether the patient's signs and symptoms are the result of an infection with Coronavirus SARS-CoV-2 (COVID-19), Human Rhinovirus, Influenza A virus, Influenza B virus, and/or Respiratory Syncytial Virus (RSV) within about 15 minutes so that randomization and
More news about: Altesa Biosciences Inc.
Sep 09, 2025, 08:00 ET Danaher Corporation (NYSE: DHR) Investor Alert: Schubert Jonckheer Investigating Possible False Claims, $73 Million in Stock Sales
October 2023, Danaher misled investors by falsely claiming that revenues from its bioprocessing division during the peak of the COVID-19 pandemic were sustainable despite knowing that demand was waning, pharmaceutical customers were relying on inventory stockpiles, and smaller biotech
More news about: Schubert Jonckheer & Kolbe LLP
Sep 09, 2025, 08:00 ET Warner Communications Salutes American Logistics Aid Network (ALAN)
California winter storms, the attacks on Ukraine, U.S. southern border response and the COVID-19 pandemic. To learn more, visit
More news about: Warner Communications LLC
Sep 09, 2025, 04:50 ET Seegene und Springer Nature eröffnen Bewerbungsverfahren für die Nature Awards MDx Impact Grants 2025-2026
und Vertrieb im Zusammenhang von syndromischen Echtzeit-PCR-Technologien. Dieses Fachwissen wurde, während der COVID-19-Pandemie besonders deutlich, als Seegene mehr als 340 Millionen COVID-19-Tests an mehr als 100 Länder weltweit lieferte. Das Hauptmerkmal der syndromischen Echtzeit-PCR-Technologie von
More news about: Seegene Inc.
Sep 09, 2025, 00:33 ET Seegene y Springer Nature Abren Convocatoria para los Nature Awards MDx Impact Grants 2025-2026
y desarrollo, fabricación y comercialización de pruebas sindrómicas de PCR en tiempo real. Durante la pandemia de COVID-19, Seegene suministró más de 340 millones de pruebas a más de 100 países, lo que refleja su impacto global. La tecnología sindrómica de PCR cuantitativa
More news about: Seegene Inc.
Sep 08, 2025, 23:38 ET The Church of Jesus Christ of Latter-day Saints Releases Photo of President Nelson on the Eve of His 101st Birthday
reinforcing the sacred nature of that name.March 2020: Led the Church in adapting to the start of the global COVID-19 pandemic, including innovations in online missionary work and ways Church members could worship together and minister to each other remotely.2018–Present: Continues
More news about: The Church of Jesus Christ of Latter-day Saints
Sep 08, 2025, 11:00 ET ABMS Announces a Record Number of ABMS Scholars for the 2025-2026 Cohort
Theodorou, MD, FACP, FHM – Feinberg School of Medicine, Northwestern UniversityProject: Post-COVID-19 Pandemic Professional Identity Among Internal Medicine ResidentsAmerican Board of Obstetrics and Gynecology
More news about: American Board of Medical Specialties
Sep 08, 2025, 10:30 ET Automotive Bearing Market is expected to generate a revenue of USD 38.31 Billion by 2031, Globally, at 6.12% CAGR: Verified Market Research®
Barriers:The global nature of automotive manufacturing leaves the bearing market vulnerable to disruptions. Events like the COVID-19 pandemic and geopolitical conflicts disrupt logistics and production.Delays in raw material sourcing lead to longer lead times for OEMs.Trade
More news about: Verified Market Research
Sep 08, 2025, 10:15 ET Barbeque Grills Market Size Is Expected To Reach US$ 7.58 Billion By 2031 at A CAGR Of 5.1% |The Insight Partners
social media food content, individuals are seeking new and enjoyable ways to cook, and grilling offers a unique, flavorful option.The COVID-19 pandemic further accelerated this trend, encouraging people to invest in home cooking equipment, including barbeque grills, as dining out became less
More news about: The Insight Partners
Sep 08, 2025, 10:01 ET Disposable Medical Device Market worth US$144.85 billion by 2030 with 4.9% CAGR | MarketsandMarkets™
economic factors. One of the primary drivers is the increasing global focus on infection prevention and control, especially in the aftermath of the COVID-19 pandemic, which highlighted the risks associated with reusable medical equipment. The rising prevalence of chronic diseases, such as diabetes, cancer,
More news about: MarketsandMarkets
Sep 08, 2025, 08:45 ET Shareholders that lost money on Lineage, Inc.(LINE) should contact The Gross Law Firm about pending Class Action - LINE
customer demand, as additional cold-storage supply had come on line, the Company's customers destocked a glut of excessive inventory built up during the COVID-19 pandemic, and the Company's customers shifted to maintaining leaner cold-storage inventories on a go-forward basis in response to changed consumer
More news about: The Gross Law Firm
Sep 08, 2025, 08:00 ET Silent Vascular Threat: Nearly 70% of Americans Unaware of PAD - The Leading Cause of Preventable Amputations
Despite vascular disease dominating headlines in recent months—from prominent public figures with visible symptoms and diagnoses to studies showing COVID-19 accelerates vascular aging in women—most Americans remain unaware of the risks. According to a recent national survey by the Society for Vascular
More news about: Society for Vascular Surgery
Sep 08, 2025, 07:00 ET CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day
FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved or cleared in the United States. The Company has numerous
More news about: Cytosorbents Corp
Sep 08, 2025, 06:45 ET Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïve CLL/SLL
decreased platelet count (29%), diarrhea (24%), COVID-19 (22%), bruising (21%), cough (20%). Mantle Cell Lymphoma Serious ARs occurred in 38% of patients. Serious ARs occurring in ≥2% of patients were pneumonia (14%), COVID-19 (4.7%), musculoskeletal pain (3.9%), hemorrhage
More news about: Eli Lilly and Company
Sep 07, 2025, 20:03 ET Seegene et Springer lancent l'appel à candidatures pour les bourses Nature Awards MDx Impact Grants 2025-2026
recherche et le développement, la fabrication et la commercialisation de technologies de PCR syndromiques en temps réel. Au cours de la pandémie de COVID-19, Seegene a fourni plus de 340 millions de tests à plus de 100 pays, ce qui souligne sa capacité à créer un impact mondial. La technologie
More news about: Seegene Inc.
Sep 07, 2025, 03:22 ET Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer
≥2% of patients included rash, pneumonia, ILD, pulmonary embolism, vomiting, and COVID-19. Fatal adverse reactions occurred in 7 patients (4.6%) due to pneumonia, cerebrovascular accident, cardio-respiratory arrest, COVID-19, sepsis, and death not otherwise specified. RYBREVANT® as
More news about: Johnson & Johnson
Sep 06, 2025, 03:00 ET RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer
≥2% of patients included rash, pneumonia, ILD, pulmonary embolism, vomiting, and COVID-19. Fatal adverse reactions occurred in 7 patients (4.6%) due to pneumonia, cerebrovascular accident, cardio-respiratory arrest, COVID-19, sepsis, and death not otherwise specified. RYBREVANT® as
More news about: Johnson & Johnson
Sep 05, 2025, 21:51 ET シージェンとスプリンガー・ネイチャーが 2025-2026年度ネイチャーアワードMDxインパクトグラントの申請受付を開始
st クレブシニア・ニューモニエの迅速検出にフォーカスしたプロジェクトをサポートしました。 シージェンについて シージェン株式会社は、症候群別リアルタイムPCR技術の研究開発、製造、商業化において20年以上のノウハウを誇る分子診断分野のグローバルリーダーです。COVID-19パンデミック期間中、シージェンは世界100カ国以上に3億4000万件以上の検査キットを供給し、その国際的な影響力を示しました。 シージェン独自の症候群定量PCR技術により、単一チューブ内で最大で14種類の類似症状を引き起こす病原体を同時に検出することが可能です。マルチ
More news about: Seegene Inc.